Skip to main content
TeamingIndex
Unclaimed profileSeeded from SAM.gov and USAspending public records
Claim this profileCapability statement (.md)

ACTELION PHARMACEUTICALS US, INC.

  • TITUSVILLE, NJ 08560-1504
  • Corporate Entity (Not Tax Exempt)
UEIH5BMHLMMNA28CAGE33TN9NAICS325412
  • SAM expiring
  • No verified credentials yet
  • CMMCNot on file
  • SPRSNone
  • FCLVisible to paid members

Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works

36-mo obligations
$6.4M
Awards on record
99
Contract vehicles
0
Verified credentials
0

SAM.gov registration expires in 7 days

ACTELION PHARMACEUTICALS US, INC.’s registration expires on Nov 20, 2026. Renewal can take weeks; confirm it stays active through proposal submission and award.

View on SAM.gov (opens in a new tab)Learn more about SAM registration and the UEI

About ACTELION PHARMACEUTICALS US, INC.

ACTELION PHARMACEUTICALS US, INC. is a SAM.gov-registered entity based in TITUSVILLE, NJ 08560-1504. UEI H5BMHLMMNA28; CAGE 33TN9; primary NAICS 325412. Compliance posture not provided. SAM registration expires in 7 days.
Headquarters
TITUSVILLE, NJ 08560-1504

Identifiers

UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.

  • UEIH5BMHLMMNA28
  • CAGE33TN9

Capabilities & differentiators

No capability narrative yet

The company has not published a capability narrative. Its SAM.gov registration, NAICS codes and award history are below.
Is this your company? Claim it

Compliance posture

Every credential shows who vouches for it: verified by TeamingIndex, or self-attested by the contractor.

No compliance posture published yet

Compliance facts appear once the company claims this profile and publishes them.
Is this your company? Claim it

Facility clearance

Facility clearance: visible to paid members

Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans

Past performance

Recompete RadarLearn more about past performance
Prime awards from USAspending.gov (FPDS), synced nightly. Recompete windows use the potential end date (base plus all options).
36-month obligations
$6.4M
Awards on record
99
Top funding agencies
Department of Veterans Affairs · Federal Prison System / Bureau of Prisons

25 most recent of 99 awards

  • 15B50527F00000036

    Recompete < 6 mo: Potential end Nov 30, 2026 (under a month away)

    VELETRI 1.5MG SDV NOV FY27 $53.43 X 120 $6411.60

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $6.4K
    Period of performance
    Nov 1, 2026 – Nov 30, 2026
    AI brief for award 15B50527F00000036Bid team for the recompete of award 15B50527F00000036

  • 15B50527F00000037

    Recompete < 6 mo: Potential end Nov 30, 2026 (under a month away)

    CURASCRIPT, (1)UPTRAVI 200MCG 60 CT BOTTLE NOV FY27

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $15.1K
    Period of performance
    Nov 1, 2026 – Nov 30, 2026
    AI brief for award 15B50527F00000037Bid team for the recompete of award 15B50527F00000037

  • 15B50927F00000004

    Completed: Period of performance ended Oct 31, 2026

    FY27-PHARMACY

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $70.3K
    Period of performance
    Oct 1, 2026 – Oct 31, 2026

  • 15B50527F00000002

    Completed: Period of performance ended Oct 21, 2026

    CURASCRIPT, (1)UPTRAVI 200MCG 60 CT BOTTLE OCT FY27

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $15.1K
    Period of performance
    Oct 21, 2026 – Oct 21, 2026

  • 15B50527F00000004

    Completed: Period of performance ended Oct 21, 2026

    VELETRI 1.5MG SDV OCTOBER FY27 $53.43 X 120 $6411.60

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $6.4K
    Period of performance
    Oct 21, 2026 – Oct 21, 2026

  • 15B50926F00000100

    Completed: Period of performance ended Sep 30, 2026

    FY26-PHARMACY ACTELION (UPTRAVI/OPSUMIT) SEPTEMBER

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $96K
    Period of performance
    Sep 1, 2026 – Sep 30, 2026

  • 15B50526F00000181

    Completed: Period of performance ended Sep 30, 2026

    VELETRI 1.5MG SDV JULYAUGUST/SEPTEMBER FY26

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $19.2K
    Period of performance
    Jul 1, 2026 – Sep 30, 2026

  • 15B50526F00000184

    Completed: Period of performance ended Sep 30, 2026

    CURASCRIPT, (1)UPTRAVI 200MCG 140 TAB+800MCGX60TB TT PK (1)UPTRAVI 200MCG TAB 60/BTL+(3)UPTRAVI 200MCG TAB 60/BTL

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $50.2K
    Period of performance
    Jul 1, 2026 – Sep 30, 2026

  • 36C26026F0017

    Completed: Period of performance ended Sep 30, 2026

    UPTRAVI 800MCG TABS

    Department of Veterans Affairs

    Obligated
    $406.5K
    Period of performance
    Oct 1, 2025 – Sep 30, 2026

  • 36C26026F0024

    Completed: Period of performance ended Sep 30, 2026

    PHARM - VELETRI

    Department of Veterans Affairs

    Obligated
    $65.5K
    Period of performance
    Oct 1, 2025 – Sep 30, 2026

  • 15B50926F00000099

    Completed: Period of performance ended Aug 31, 2026

    FY26-PHARMACY ACTELION (UPTRAVI/OPSUMIT) AUGUST

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $46.9K
    Period of performance
    Aug 1, 2026 – Aug 31, 2026

  • 15B50926F00000098

    Completed: Period of performance ended Jul 31, 2026

    FY26-PHARMACY ACTELION (UPTRAVI/OPSUMIT) JULY

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $85.4K
    Period of performance
    Jul 1, 2026 – Jul 31, 2026

  • 15B50526F00000169

    Completed: Period of performance ended Jul 31, 2026

    OPSUMIT 10MG-QTY 3 @ $12,853.56 MAY ORDER HOME CONFINEMENT 90 DAYS' SUPPLY

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $38.6K
    Period of performance
    May 1, 2026 – Jul 31, 2026

  • 36C26025F0209

    Completed: Period of performance ended Jul 20, 2026

    UPTRAVI 1600MCG TAB

    Department of Veterans Affairs

    Obligated
    $197.2K
    Period of performance
    Jul 21, 2025 – Jul 20, 2026

  • 15B50926F00000097

    Completed: Period of performance ended Jun 30, 2026

    FY26-PHARMACY ACTELION (UPTRAVI/OPSUMIT) JUNE

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $77.1K
    Period of performance
    Jun 1, 2026 – Jun 30, 2026

  • 15B50926F00000096

    Completed: Period of performance ended May 31, 2026

    FY26-PHARMACY ACTELION (UPTRAVI/OPSUMIT) MAY

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $100.5K
    Period of performance
    May 1, 2026 – May 31, 2026

  • 36C24526N0477

    Completed: Period of performance ended May 15, 2026

    OPSUMIT 10 MG

    Department of Veterans Affairs

    Obligated
    $47.1K
    Period of performance
    Apr 3, 2026 – May 15, 2026

  • 15B50526F00000121

    Completed: Period of performance ended Apr 30, 2026

    FY26 APR OPSUMIT ACTELION/CURASCRIPT ORDER OPSUMIT 10MG-QTY 2 @ 6,426.78 $12,853.56

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $12.9K
    Period of performance
    Apr 1, 2026 – Apr 30, 2026

  • 15B50926F00000095

    Completed: Period of performance ended Apr 30, 2026

    FY26-PHARMACY APRIL

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $62K
    Period of performance
    Apr 1, 2026 – Apr 30, 2026

  • 15B50526F00000106

    Completed: Period of performance ended Mar 31, 2026

    OPSUMIT 10MG-QTY 2 @ 6,426.78 MARCH ORDER - $12,853.56

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $12.9K
    Period of performance
    Mar 1, 2026 – Mar 31, 2026

  • 15B50926F00000064

    Completed: Period of performance ended Mar 31, 2026

    FY26-PHARMACY MARCH

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $62K
    Period of performance
    Mar 1, 2026 – Mar 31, 2026

  • 15B50926F00000155

    Completed: Period of performance ended Mar 31, 2026

    FY26-PHARMACY MARCH

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $62K
    Period of performance
    Mar 1, 2026 – Mar 31, 2026

  • 15B50926F00000054

    Completed: Period of performance ended Feb 28, 2026

    FY26-PHARMACUTICALS

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $62K
    Period of performance
    Feb 28, 2026 – Feb 28, 2026

  • 15B50526F00000092

    Completed: Period of performance ended Feb 28, 2026

    OPSUMIT 10MG-QTY 2 @ 6,426.78 FEB. ORDER - $12,853.56

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $12.9K
    Period of performance
    Feb 1, 2026 – Feb 28, 2026

  • 15B50926F00000148

    Completed: Period of performance ended Feb 28, 2026

    FY26-PHARMACY ACTELION (UPTRAVI/OPSUMIT) FEBRUARY

    Department of Justice · Federal Prison System / Bureau of Prisons

    Obligated
    $62K
    Period of performance
    Feb 1, 2026 – Feb 28, 2026

Contract vehicles

Learn more about GWACs, IDIQs and contract vehicles

No contract vehicles on file

This company has not listed GWAC, IDIQ, GSA Schedule or OTA consortium holdings.
Browse vehicle holders

Proven teaming graph

Learn more about sub-award reporting (FSRS)
Who ACTELION PHARMACEUTICALS US, INC. has actually worked with, from sub-awards that prime contractors report to the government. Use it to see which primes already trust this company.

No sub-award reports yet

Prime contractors report first-tier subcontracts of $30,000 or more. None name this company yet, which is common for companies that mostly win prime contracts or work below the reporting threshold.
See where agencies spend

Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.

SBIR/STTR portfolio

Learn more about SBIR/STTR Phase IIIAbout SBIR/STTR (opens in a new tab)
Small Business Innovation Research and Technology Transfer awards: early-stage federal R&D money this company has won.

No SBIR/STTR awards on record

Awards appear here automatically after SBIR.gov publishes them.
Browse SBIR/STTR awardees

Source: SBIR.gov award records (opens in a new tab) · sync date not recorded

FedRAMP offerings

Learn more about the FedRAMP Marketplace
Cloud services this company lists on the FedRAMP Marketplace, the government's record of cloud authorizations.

No FedRAMP Marketplace listing

No FedRAMP Marketplace listing is linked to this company. Cloud providers appear here automatically once FedRAMP lists their offering.
Find FedRAMP-authorized companies

Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded

Exclusions & screening

Exclusions about SAM.gov exclusionsScreening list about the Consolidated Screening List
Checks a prime runs before teaming: SAM.gov exclusions (debarment and suspension) and the government's Consolidated Screening List for export and sanctions lists.

SAM.gov exclusions

Not yet checked against SAM.gov exclusions.

Search exclusions on SAM.gov (opens in a new tab)

Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.

Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded

Consolidated Screening List

No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).

The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.

Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026

GSA CALC+ rate benchmark

Learn more about GSA CALC+ labor rates
Hourly ceiling rates this company was awarded on GSA contracts, compared with the market for similar labor categories. Ceiling rates are the most an agency can be charged, not prices paid.

No GSA CALC+ rates on record

Companies with a GSA Multiple Award Schedule contract appear here after CALC+ publishes their awarded labor rates.
See GSA MAS holders

Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded

NAICS, PSC & socio-economic status

Learn more about NAICS size standards
Industry codes and small-business programs reported in SAM.gov.

NAICS codes

  • 325412Pharmaceutical Preparation ManufacturingPrimary

SAM.gov does not report this entity as small under any listed NAICS code.

Socio-economic status

No socio-economic certifications reported in SAM.gov.

Product & service codes (PSC)

No PSC codes reported.

Teaming preferences

Learn more about teaming agreements and joint ventures

This company has not published teaming preferences.

SAM.gov teaming eligibility: Eligible to be proposed as a team member: active SAM.gov registration and no exclusion.

Business development contact

No BD contact published

Contact details appear once the company claims this profile.
Is this your company? Claim it

Corporate hierarchy

Affiliation & size about affiliation and size
Immediate parent and highest-level owner as reported in SAM.gov.

No parent entity reported in SAM.gov.

SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.

Data sources & provenance

Who stands behind each fact on this page, and how to correct it.

  • SAM.gov

    Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.

  • USAspending.gov

    Prime award history and obligations (FPDS), synced nightly.

  • The contractor

    Nothing yet: this profile has not been claimed by the company.

  • TeamingIndex verification

    Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.

Corrections

Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)

Machine-readable: capability.md schema.org JSON-LD embedded in this page.

Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.

Teaming

Ready to team with ACTELION PHARMACEUTICALS US, INC.?

Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.

Claim this profileCapability statement (.md)